imatinib mesylate has been researched along with Leukemia, Megakaryocytic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Seraihy, A; Al-Shehri, A; Belgaumi, AF; Owaidah, TM | 1 |
| Chondropoulos, S; Dervenoulas, J; Economopoulos, T; Economopoulou, C; Ionnidou, ED; Konsioti, F; Papageorgiou, E; Papageorgiou, SG; Pappa, V; Tsirigotis, P; Vasilatou, D | 1 |
| Ascani, S; Bonomini, S; Caramatti, C; Colla, S; Craviotto, L; Crugnola, M; De Celis, I; Giuliani, N; Hojden, M; Morandi, F; Rizzoli, V; Sabbatini, E; Sammarelli, G | 1 |
| Fukuda, S; Pelus, LM; Sampath, J; Wang, Z | 1 |
| Boggon, TJ; Crispino, J; Deininger, MW; Druker, BJ; Eide, CA; Gilliland, DG; Goss, VL; Gu, TL; Heinrich, MC; Lee, KA; Loriaux, M; McGreevey, L; Mercher, T; Moore, SA; Nardone, J; O'Hare, T; Polakiewicz, RD; Stoffregen, EP; Tyner, JW; Walters, DK; Wong, MJ | 1 |
| Corm, S; Grardel, N; Preudhomme, C; Quesnel, B; Rad-Quesnel, E; Renneville, A | 1 |
| Druker, BJ; Kolibaba, KS; Ohno-Jones, S; Thiesing, JT | 1 |
1 review(s) available for imatinib mesylate and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction | 2004 |
6 other study(ies) available for imatinib mesylate and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
Megakaryocytic blast crisis at presentation in a pediatric patient with chronic myeloid leukemia.
Topics: Antineoplastic Agents; Benzamides; Blast Crisis; Child; Cord Blood Stem Cell Transplantation; Diagnosis, Differential; Female; Humans; Imatinib Mesylate; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Megakaryocytes; Piperazines; Pyrimidines; Remission Induction; Treatment Outcome | 2010 |
Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression.
Topics: Antineoplastic Agents; Benzamides; Central Nervous System Neoplasms; Dasatinib; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Philadelphia Chromosome; Piperazines; Pyrimidines; Remission Induction; Thiazoles | 2010 |
Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Benzamides; Caspase 9; Caspases; Cell Line, Tumor; Cytochromes c; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Inhibitor of Apoptosis Proteins; K562 Cells; Leukemia, Megakaryoblastic, Acute; Membrane Glycoproteins; Mice; Microtubule-Associated Proteins; Neoplasm Proteins; Oligonucleotides, Antisense; Piperazines; Pyrimidines; RNA, Messenger; Signal Transduction; Survivin; TNF-Related Apoptosis-Inducing Ligand; Transduction, Genetic; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
Activating alleles of JAK3 in acute megakaryoblastic leukemia.
Topics: Alleles; Animals; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Imatinib Mesylate; Janus Kinase 2; Janus Kinase 3; K562 Cells; Leukemia, Experimental; Leukemia, Megakaryoblastic, Acute; Mice; Mice, Inbred C57BL; Models, Molecular; Mutant Proteins; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyrimidines; RNA, Small Interfering; TYK2 Kinase | 2006 |
Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
Topics: Adult; Aged; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Female; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Piperazines; Pyrimidines; Recombinant Fusion Proteins; Thiazoles; Transplantation Conditioning; Treatment Outcome | 2007 |
Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells.
Topics: Antineoplastic Agents; Benzamides; Blast Crisis; Cell Division; Cell Survival; Cytarabine; Daunorubicin; Fusion Proteins, bcr-abl; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxyurea; Imatinib Mesylate; Interleukin-3; Leukemia, Megakaryoblastic, Acute; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcr; Pyrimidines; Stem Cell Factor; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |